ADRX
ADRX: Fisk Ryan discloses securities transactions
Fisk Ryan reported Grant or award in ADARx Pharmaceuticals, Inc.: 170692 units of Employee Stock Option (right to buy) (derivative), dated 2026-09-24. The full Form 4 contains 1 transaction entry.